Acts directly on endometriotic tissue as well as on ovarian hormones
Partial oestrogen suppression allows longer courses than stronger agents
Manufactured at a WHO-GMP certified facility under GLP and ISO norms
Every batch quality tested in-house before dispatch
Indications of Degostin-2
Endometriosis
Pelvic pain from endometriosis
Adenomyosis
How Degostin-2 works
Dienogest is a progestogen with a specific action in endometriosis. It suppresses ovarian oestrogen production moderately and acts directly on the endometriotic tissue itself, causing it to become inactive and shrink. Because the oestrogen suppression is only partial, the bone loss that stronger suppression causes is largely avoided, which allows longer treatment.
Why ChooseDegostin-2?
Manufactured at a WHO-GMP certified facility under GLP, ISO and GMP norms, with raw material from approved vendors and in-house quality testing on every batch. A large share of this range is taken during pregnancy or over long periods, so consistency between batches is treated as a requirement rather than a target. Offered to PCD franchise partners on district-wise monopoly rights, with pan-India supply and complete promotional support.
Frequently asked questions about Degostin-2
Is monopoly available for this product?
Yes. District-wise monopoly rights are offered across India. Tell us your district and we will confirm availability.
What is the composition of Degostin-2?
Dienogest 2 mg.
Is this manufactured at a WHO-GMP certified facility?
Yes. Manufacturing follows GLP, WHO, ISO and GMP norms, and every batch is quality tested in-house before dispatch.
What is the minimum order quantity?
Please contact our team for the current MOQ and price structure for your territory.
Last updated on 29 August 2026
This information is for reference only and is not a substitute for advice from a qualified doctor or pharmacist. Please consult your physician before use.
Cista Medicorp
